Skip to main content
Clinical Trials/NCT03295045
NCT03295045
Completed
Not Applicable

Evolution of the Profile of Infectious Endocarditis in France in 2008

Centre Hospitalier Universitaire de Besancon0 sites484 target enrollmentDecember 1, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infective Endocarditis
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
484
Primary Endpoint
Mortality
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Infective endocarditis (IE) is a rare (30 cases / million / year in France) and serious (20 % of deaths during hospitalization) disease . Its epidemiological profile was considerably modified these last years.New predisposing factors appeared, due to increasing number of patients wearing valvular prosthetics. The purpose of this study is to realize in 2008 a new observational study on populational basis to describe and analyze the evolution of the epidemiology of IE in France, compared to previous studies conducted in 1991 and 1999.

Detailed Description

It is a prospective observational study based on a population of 25 million inhabitants. The cases are recruited over a one year period, from January 1st till December 31st, 2008, in six regions of France (Rhône-Alpes, Paris et Petite Couronne, Lorraine, Franche-Comté, Marne, Languedoc-Roussillon) and in the department of Ille-et-Vilaine. The IE cases are declared by clinicians taking care of the patients, microbiologists and cardiac ultrasonographists.

Registry
clinicaltrials.gov
Start Date
December 1, 2007
End Date
December 31, 2010
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Major Patient
  • Supported in one of the participating centers
  • The application of diagnostic classification criteria of Duke modified by Li is carried out after collection of all the data at the output of the patient. Will be included in the observatory that patients meeting criteria for definite or possible endocarditis.
  • Affiliated with the French social security regime

Exclusion Criteria

  • Patients not living in one of the studied regions

Outcomes

Primary Outcomes

Mortality

Time Frame: 1 year

Vital status

Secondary Outcomes

  • Frequency of antibiotic resistance by the germs (streptococci and staphylococci)(during the hospitalization, 1 year maximum)

Similar Trials